Health Care & Life Sciences » Pharmaceuticals | Kadmon Holdings Inc.

Kadmon Holdings Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
20,991.00
21,498.00
36,093.00
67,517.00
94,740
Total Accounts Receivable
2,086.00
3,395.00
1,210.00
1,186.00
1,690
Inventories
7,672.00
3,468.00
1,950.00
201.00
925
Other Current Assets
1,249.00
4,380.00
978.00
1,109.00
1,581
Total Current Assets
31,998.00
32,741.00
40,231.00
70,013.00
98,936
Net Property, Plant & Equipment
9,121.00
6,938.00
5,427.00
4,292.00
3,654
Total Investments and Advances
4,325.00
25,640.00
13,257.00
5,658.00
38,491
Intangible Assets
77,514.00
18,803.00
3,580.00
3,580.00
3,580
Other Assets
10.00
15.00
61.00
9.00
-
Total Assets
122,968.00
84,137.00
62,556.00
83,552.00
151,166
ST Debt & Current Portion LT Debt
15,500.00
6,150.00
1,900.00
33,707.00
Accounts Payable
9,729.00
5,902.00
6,296.00
8,008.00
Other Current Liabilities
26,342.00
37,634.00
16,550.00
14,929.00
Total Current Liabilities
51,571.00
49,686.00
24,746.00
56,644.00
Long-Term Debt
149,406.00
209,721.00
28,677.00
-
Deferred Taxes
1,352.00
1,349.00
1,376.00
939.00
Other Liabilities
39,007.00
35,434.00
32,949.00
24,211.00
Total Liabilities
241,336.00
296,190.00
87,748.00
81,794.00
Common Equity (Total)
155,420.00
270,909.00
63,494.00
38,462.00
Total Shareholders' Equity
118,368.00
212,053.00
25,192.00
1,758.00
Total Equity
118,368.00
212,053.00
25,192.00
1,758.00
Liabilities & Shareholders' Equity
122,968.00
84,137.00
62,556.00
83,552.00
Preferred Stock (Carrying Value)
37,052.00
58,856.00
38,302.00
40,220.00

About Kadmon Holdings

View Profile
Address
450 East 29th Street
New York New York 10016
United States
Employees -
Website http://www.kadmon.com
Updated 07/08/2019
Kadmon Holdings, Inc. is a biopharmaceutical company, which engages in discovering, developing, and commercializing small molecules and biologics. Its products include Ribasphere RibaPak, Tetrabenazine, Valganciclovir, Abacavir, Entecavir, Lamivudine, and Zidovudine. The company was founded by Steven N.